Squarepoint
ATRC icon

Squarepoint’s AtriCure ATRC Stock Holding History

Squarepoint’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,800
Closed -$511K – 4040
2024
Q1 		$511K Buy
+16,800
New +$563K ﹤0.01% 3031

Other funds holding ATRC

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Champlain Investment Partners
Champlain Investment Partners Burlington, Vermont $2.9B AUM 23.58% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Panagora Asset Management
Panagora Asset Management Boston, Massachusetts $33.2B AUM 43.67% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Squarepoint's ATRC Position: Q3 2026 in Review

Squarepoint opened a new position in AtriCure (ATRC) in Q3 2026: 9,913 shares worth $557K. The stake represents ﹤0.01% of the portfolio and ranks #3289 among its holdings. This is a return to the name: Squarepoint previously reported a position in ATRC as recently as Q4 2025.

Squarepoint first reported a position in ATRC in Q3 2017 and has held it in 26 quarters since. The position peaked at $6.16M in Q3 2025. 183 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.

  • Squarepoint held 9,913 shares of AtriCure worth $557K as of Q3 2026.
  • AtriCure was a new Squarepoint position in Q3 2026.
  • AtriCure made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #3289 holding.
  • Squarepoint first reported a position in AtriCure in Q3 2017 and has held it in 26 quarters since.
  • Squarepoint's AtriCure position peaked at $6.16M in Q3 2025.
  • 183 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.